A Comparison of 18F-PSMA-1007 and 64Cu-PSMA in 2 Patients With Metastatic Prostate Cancer.
Clin Nucl Med
; 47(2): e120-e122, 2022 Feb 01.
Article
de En
| MEDLINE
| ID: mdl-34115708
ABSTRACT
ABSTRACT 18F-prostate-specific membrane antigen (PSMA) 1007 is one of the most promising radiotracers for PET imaging in prostate cancer, minimal urinary clearance, and higher spatial resolution, which are the most outstanding features. PSMA can also be labeled with 64Cu, offering a longer half-life and different resolution imaging. We present images of metastatic prostate cancer in two patients, where 64Cu-PSMA PET/CT was performed one day after 18F-PSMA-1007 PET/CT. In the two patients, both radiotracers provided high image quality and a similar range of detection for metastatic lesions.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs de la prostate
/
Radio-isotopes du cuivre
Limites:
Humans
/
Male
Langue:
En
Journal:
Clin Nucl Med
Année:
2022
Type de document:
Article
Pays d'affiliation:
Mexique